Back in 2000, the California Public Employees’ Retirement System (Calpers) sold all of its positions in tobacco stocks and enacted a ban on future investments in tobacco-related companies. According Calpers spokeswoman Megan White, “concerns over ongoing litigation and regulatory risks facing the tobacco industry prompted the Investment Committee to divest.”
However, their third-quarter filing shows that they have a small hold in Tilray stock. Tilray is a Canadian pharmaceutical company known as one of the leading medical cannabis producers in the world. When asked why Calpers would rather invest in cannabis stock than tobacco, White replied, “The board does not make decisions about buying stocks. The investment office has delegated authority.”
In December 2016, staff at Calpers suggested lifting the ban on tobacco investments, despite acknowledging the many negative societal implications of tobacco, primarily related to health and medical costs. Jim Currie, Executive Director of the Commissioned Officers Association of the U.S. Public Health Service had this to say about their proposal:
“I hope that you will not do this (end the ban) for two reasons: (1) you will not gain investment income by providing financial support to entities that are killing hundreds of thousands of people a year with their products, and (2) you have such a presence in the world of investment that your decision might well trigger a stampede in that direction.”
Additionally, a letter from the American Heart Association and the American Lung Association of California actually recommended that Calpers expand the restrictions. “Investing in tobacco would pit Calpers’s portfolio against the financial and physical well-being of its members and the rest of California,” the groups said. “We also urge Calpers to take this opportunity to close the loophole in its policy which currently exempts third-party fund managers from divestment requirements.”
Advocates of the tobacco ban aren’t pushing the company to cut ties with cannabis companies. “We have not considered marijuana at this time,” Currie said in an email, “ A spokeswoman for the American Cancer Society Cancer Action Network also commented that it “has not taken a position on [Calpers’] investment in marijuana stocks.
In any case, Tilray isn’t the fund’s only cannabis-related deal. Calpers also owns shares of Constellation Brands, who has a 38% stake in Canopy Growth, and they also own 37,100 American depositary receipts of GW Pharmaceuticals, a U.K developer of cannabis-based prescription medications such as Epidiolex.
The post California Pension Fund Invests in Cannabis While Shunning Tobacco appeared first on Cannadelics.
As cannabis laws continue to change at bewildering speeds, the topic of employee workplace protections becomes increasingly relevant. Honestly, with how many people support legalization these days and the astronomical inflation we’ve been experiencing, it makes no sense that cannabis users should have to struggle to find decent jobs. Some states are taking action by […]
The post 7 States Where Cannabis Users Can Easily Find Jobs appeared first on Cannadelics.
The island nation of New Zealand has relied on exports to treat medical cannabis patients so far. Allowing the dispensation of domestically cultivated cannabis will help the nascent industry grow and lower overall costs. Last week, New Zealand officials approved the beginning of the domestically sourced medical cannabis market. The Department of Health began allowing […]
A link to your site, with your site's name and description as anchor text.
Inventory Clearance Sale
Save 60% Off all remaining inventory with Promo Code: ICE